Regeneron inks big new coronavirus antibody supply deal worth up to $2.6B Verily sees big opportunities to help reopen businesses in 2021 Woodcock to step up to interim FDA chief as she and Sharfstein are vetted for permanent job: reports Much has changed since H1N1. CVS and Walgreens execs discuss how pharmacists have become key to fighting pandemics CDMO Catalent tackles Warp Speed juggling act with new $50M Bloomington line, Acorda plant buyout Alexion's Ultomiris falls short in COVID-19 trial after months of testing in severe patients Moderna hitches a ride with Uber to boost vaccine confidence—and, of course, drive access Can we take J.P. Morgan out of San Francisco? We're virtually there How a timely acquisition helped NextGen Healthcare weather COVID-19 Biopharma roundup: Microsoft, Mayo Clinic and more team up on digital vaccination pass Featured Story | By Eric Sagonowsky Pharma companies worldwide scrambled to respond to the COVID-19 pandemic early last year, but so far only a few have advanced therapies and vaccines through to the market. Regeneron is one, and now the drugmaker's antibody cocktail could bring a multibillion-dollar windfall in 2021. read more |
| |
|---|
|
| | Webinar: 2021 Apollo Healthcare Predictions Thursday, February 4, 2021 | 1pm ET / 10am PT With so much disruption from COVID-19, this year’s global insights will provide a unique window into the minds of those professionals perhaps most tested by 2020 and their hopes and perspectives for 2021. Register Now! |
Top Stories By Heather Landi Leveraging its technology capabilities, Verily sees big opportunities to expand its work with employers through its Healthy at Work program. Verily executive Vivian Lee outlines why data science and digital health will play a big role in getting employees safely back into offices. read more By Beth Snyder Bulik FDA veteran Janet Woodcock will take over as commissioner, at least temporarily, when current chief Stephen Hahn departs, according to media reports. President-elect Joseph Biden has tapped Woodcock as interim FDA commissioner while his team searches for a permanent replacement, both BioCentury and Pink Sheet reported today. read more By Tina Reed Already, Operation Warp Speed, which is the federal effort behind creating and distributing vaccines to Americans, contracted Walgreens and CVS Health to administer vaccines in long-term care facilities. But experts say pharmacies will play a key role in getting this vaccine out across priority levels. read more By Fraiser Kansteiner Operation Warp Speed has forced Catalent to set aside some of its regular manufacturing work to handle COVID-19 orders, and that's triggered at least one drug shortage. But with a new production line set to open up in Bloomington in April—and a new plant purchase announced Tuesday—the capacity jam could start to abate. read more By Eric Sagonowsky About a year after the initial COVID-19 outbreak, pharma companies have learned a lot about which drugs to repurpose as potential treatments. And after testing in severe patients for several months, one drug that hasn’t panned out, at least so far, is Alexion’s rare disease med Ultomiris. read more By Beth Snyder Bulik Moderna has a COVID-19 vaccine. Uber has a customer and driver network. Now, they've teamed up to promote confidence in coronavirus immunization and potentially get people to vaccination sites. Uber might tout vaccine safety on its network and through its app, but its most obvious role—still in the works—would be transportation. read more By Amirah Al Idrus This week's virtual J.P. Morgan Healthcare Conference gave us a rest from the behemoth the meeting has evolved into. Could it be the catalyst that gets it out of San Francisco? Reviews are mixed. Some think branding and history will keep it in town, while others thing moving the meeting won't solve its problems. read more By Heather Landi NextGen Healthcare CEO Rusty Frantz told employees, "Look, we just got an 18 wheeler of lemons dropped on our doorstep, we better start getting really good at making lemonade out of it." Here's how the medical practice technology provider quickly adapted and helped physician practices weather 2020. read more By Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale Moderna plans to work with Uber to get the word out on vaccines. A slew of tech companies and health organizations are working to develop digital vaccination credentials. Some employees are offering incentives for their staff to get vaccinated. Non-residents are flocking to Florida for vaccines. And Russia's vaccine account was briefly restricted on Twitter. read more |
